| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |